Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: April 2015

Chapter 15 - The Wnt signaling network in cancer

from Part 4 - Functional networks of events that modulate phenotypic manifestation of cancer

References

Albert, R., and Othmer, H.G. (2003). The topology of the regulatory interactions predicts the expression pattern of the segment polarity genes in Drosophila melanogaster. J Theoret Biol 223, 1–18.
Amonlirdviman, K., Khare, N.A., Tree, D.R., et al. (2005). Mathematical modeling of planar cell polarity to understand domineering nonautonomy. Science 307, 423–426.
Angers, S., and Moon, R.T. (2009). Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10, 468–477.
Aoki, K., and Taketo, M.M. (2008). Tissue-specific transgenic, conditional knockout and knock-in mice of genes in the canonical Wnt signaling pathway. Methods Mol Biol 468, 307–331.
Ashburner, M., Ball, C.A., Blake, J.A., et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25–29.
Askenazi, M., Li, S., Singh, S., and Marto, J.A. (2010). Pathway Palette: a rich internet application for peptide-, protein- and network-oriented analysis of MS data. Proteomics 10, 1880–1885.
Aulehla, A., Wehrle, C., Brand-Saberi, B., et al. (2003). Wnt3a plays a major role in the segmentation clock controlling somitogenesis. Dev Cell 4, 395–406.
Barker, N., and Clevers, H. (2006). Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5, 997–1014.
Barker, N., and van den Born, M. (2008). Detection of beta-catenin localization by immunohistochemistry. Methods Mol Biol 468, 91–98.
Barolo, S. (2006). Transgenic Wnt/TCF pathway reporters: all you need is Lef? Oncogene 25, 7505–7511.
Bayer Schering Pharma (2010). Bayer Schering Pharma and OncoMed pharmaceuticals enter strategic alliance to develop anti-cancer stem cell therapeutics. June 17, 2010. www.investor.bayer.com/en/nc/news/archive/investor-news-2010/investor-news-2010/bayer-schering-pharma-and-oncomed-pharmaceuticals-enter-strategic-alliance-to-develop-anti-cancer-st.
Beachy, P.A., Karhadkar, S.S., and Berman, D.M. (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324–331.
Beildeck, M.E., Gelmann, E.P., and Byers, S.W. (2010). Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway. Exp Cell Res 316, 1763–1772.
Biechele, T.L., and Moon, R.T. (2008). Assaying beta-catenin/TCF transcription with beta-catenin/TCF transcription-based reporter constructs. Methods Mol Biol 468, 99–110.
Boon, E.M., Keller, J.J., Wormhoudt, T.A., et al. 2004). Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer 90, 224–229.
Bottomly, D., Kyler, S.L., McWeeney, S.K., and Yochum, G.S. (2010). Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 38, 5735–5745.
Bovolenta, P., Esteve, P., Ruiz, J.M., Cisneros, E., and Lopez-Rios, J. (2008). Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 121, 737–746.
Brown, A.M., Wildin, R.S., Prendergast, T.J., and Varmus, H.E. (1986). A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell 46, 1001–1009.
Cadigan, K.M., and Liu, Y.I. (2006). Wnt signaling: complexity at the surface. J Cell Sci 119, 395–402.
Cadigan, K.M., and Peifer, M. (2009). Wnt signaling from development to disease: insights from model systems. Cold Spring Harb Perspect Biol 1, a002881.
Camilli, T.C., and Weeraratna, A.T. (2010). Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem Pharmacol 80, 702–711.
Capdeville, R., Buchdunger, E., Zimmermann, J., and Matter, A. (2002). Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1, 493–502.
Carlson, B., Lahusen, T., Singh, S., et al. (1999). Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res 59, 4634–4641.
Chang, J.T., and Nevins, J.R. (2006). GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22, 2926–2933.
Chaves, M., and Albert, R. (2008). Studying the effect of cell division on expression patterns of the segment polarity genes. J R Soc Interface 5 Suppl 1, S71–84.
Chen, B., Dodge, M.E., Tang, W., et al. (2009). Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5, 100–107.
Chen, X., Yang, J., Evans, P.M., and Liu, C. (2008). Wnt signaling: the good and the bad. Acta Biochim Biophys Sin 40, 577–594.
Chien, A.J., Conrad, W.H., and Moon, R.T. (2009). A Wnt survival guide: from flies to human disease. J Invest Dermatol 129, 1614–1627.
Chien, C.T., Bartel, P.L., Sternglanz, R., and Fields, S. (1991). The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88, 9578–9582.
Cho, K.H., Baek, S., and Sung, M.H. (2006). Wnt pathway mutations selected by optimal beta-catenin signaling for tumorigenesis. FEBS Lett 580, 3665–3670.
Choi, H.Y., Lim, J.E., and Hong, J.H. (2010). Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells. Prostate Cancer Prostatic Dis 13, 343–349.
Choudhary, C., and Mann, M. (2010). Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 11, 427–439.
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469–480.
Collins, M.O., and Choudhary, J.S. (2008). Mapping multiprotein complexes by affinity purification and mass spectrometry. Curr Opin Biotechnol 19, 324–330.
Coluccia, A.M., Benati, D., Dekhil, H., et al. (2006). SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Cancer Res 66, 2279–2286.
Croce, J.C., and McClay, D.R. (2008). Evolution of the Wnt pathways. Methods Mol Biol 469, 3–18.
Danilkovitch-Miagkova, A. (2003). Oncogenic signaling pathways activated by RON receptor tyrosine kinase. Curr Cancer Drug Targets 3, 31–40.
DasGupta, R., Kaykas, A., Moon, R.T., and Perrimon, N. (2005). Functional genomic analysis of the Wnt-wingless signaling pathway. Science 308, 826–833.
Davidson, G., Shen, J., Huang, Y.-L., et al. (2009). Cell cycle control of wnt receptor activation. Dev Cell 17, 788–799.
Davidson, G., Wu, W., Shen, J., et al. (2005). Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438, 867–872.
Dayarian, A., Chaves, M., Sontag, E.D., and Sengupta, A.M. (2009). Shape, size, and robustness: feasible regions in the parameter space of biochemical networks. PLoS Comp Biol 5, e1000256.
Dennis, G., Jr., Sherman, B.T., Hosack, D.A., et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3.
Dequeant, M.L., Glynn, E., Gaudenz, K., et al. (2006). A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 314, 1595–1598.
Dihlmann, S., Klein, S., and Doeberitz Mv, M.K. (2003). Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol Cancer Ther 2, 509–516.
Dihlmann, S., and von Knebel Doeberitz, M. (2005). Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer 113, 515–524.
Dirnberger, D., Messerschmid, M., and Baumeister, R. (2008). An optimized split-ubiquitin cDNA-library screening system to identify novel interactors of the human Frizzled 1 receptor. Nucleic Acids Res 36, e37.
Dominguez, I., Mizuno, J., Wu, H., et al. (2004). Protein kinase CK2 is required for dorsal axis formation in Xenopus embryos. Dev Biol 274, 110–124.
Dominguez, I., Sonenshein, G.E., and Seldin, D.C. (2009). Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer. Cell Mol Life Sci 66, 1850–1857.
Dumont, J.E., Pecasse, F., and Maenhaut, C. (2001). Crosstalk and specificity in signalling. Are we crosstalking ourselves into general confusion? Cell Signal 13, 457–463.
Edwards, P.A., Hiby, S.E., Papkoff, J., and Bradbury, J.M. (1992). Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. Oncogene 7, 2041–2051.
Emami, K.H., Nguyen, C., Ma, H., et al. (2004). A small molecule inhibitor of beta-catenin/CREB-binding protein transcription (corrected). Proc Natl Acad Sci USA 101, 12682–12687.
Ewing, R.M., Chu, P., Li, H., et al. (2007). Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3, 89.
Fagotto, F., Gluck, U., and Gumbiner, B.M. (1998). Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr Biol 8, 181–190.
Fields, S., and Song, O. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245–246.
Fodde, R., and Tomlinson, I. (2010). Nuclear beta-catenin expression and Wnt signalling: in defence of the dogma. J Pathol 221, 239–241.
Fu, C.A., Shen, M., Huang, B.C., et al. (1999). TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J Biol Chem 274, 30729–30737.
Galis, F., van Dooren, T.J., and Metz, J.A. (2002). Conservation of the segmented germband stage: robustness or pleiotropy? Trends Genet 18, 504–509.
Gao, C., and Chen, Y.G. (2010). Dishevelled: the hub of Wnt signaling. Cell Signal 22, 717–727.
Gavin, A.C., Bosche, M., Krause, R., et al. (2002). Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141–147.
Geng, X., Xiao, L., Lin, G.F., et al. (2003). Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification. FEBS Lett 547, 1–6.
Giles, R.H., van Es, J.H., and Clevers, H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653, 1–24.
Gingras, A.-C., Aebersold, R., and Raught, B. (2005). Advances in protein complex analysis using mass spectrometry. J Physiol 563, 11–21.
Glatter, T., Wepf, A., Aebersold, R., and Gstaiger, M. (2009). An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol 5, 237.
Goentoro, L., and Kirschner, M.W. (2009). Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling. Mol Cell 36, 872–884.
Goentoro, L., Shoval, O., Kirschner, M.W., and Alon, U. (2009). The incoherent feedforward loop can provide fold-change detection in gene regulation. Mol Cell 36, 894–899.
Goldbeter, A., and Pourquie, O. (2008). Modeling the segmentation clock as a network of coupled oscillations in the Notch, Wnt and FGF signaling pathways. J Theoret Biol 252, 574–585.
Grigoryan, T., Wend, P., Klaus, A., and Birchmeier, W. (2008). Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 22, 2308–2341.
Guger, K.A., and Gumbiner, B.M. (2000). A mode of regulation of beta-catenin signaling activity in Xenopus embryos independent of its levels. Dev Biol 223, 441–448.
Gutenkunst, R.N., Waterfall, J.J., Casey, F.P., et al. (2007). Universally sloppy parameter sensitivities in systems biology models. PLoS Comp Biol 3, 1871–1878.
Haertel-Wiesmann, M., Liang, Y., Fantl, W.J., and Williams, L.T. (2000). Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 275, 32046–32051.
Hagen, T., Sethi, J.K., Foxwell, N., and Vidal-Puig, A. (2004). Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J 379, 471–477.
Hallikas, O., Palin, K., Sinjushina, N., et al. (2006). Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124, 47–59.
Hausmann, G., Banziger, C., and Basler, K. (2007). Helping Wingless take flight: how WNT proteins are secreted. Nat Rev Mol Cell Biol 8, 331–336.
Hayward, P., Kalmar, T., and Arias, A.M. (2008). Wnt/Notch signalling and information processing during development. Development 135, 411–424.
He, B., Reguart, N., You, L., et al. (2005). Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24, 3054–3058.
Herendeen, J.M., and Lindley, C. (2003). Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother 37, 1664–1674.
Ho, Y., Gruhler, A., Heilbut, A., et al. (2002). Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180–183.
Hodar, C., Assar, R., Colombres, M., et al. (2010). Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method. BMC Genomics 11, 348.
Hu, T., and Li, C. (2010). Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9, 236.
Huang, M., Wang, Y., Sun, D., et al. (2006). Identification of genes regulated by Wnt/beta-catenin pathway and involved in apoptosis via microarray analysis. BMC Cancer 6, 221.
Huang, S., Li, Y., Chen, Y., et al. (2005). Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol 6, R84.
Huang, S.S., and Fraenkel, E. (2009). Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks. Sci Signal 2, ra40.
Ilyas, M. (2005). Wnt signalling and the mechanistic basis of tumour development. J Pathol 205, 130–144.
Ingolia, N.T. (2004). Topology and robustness in the Drosophila segment polarity network. PLoS Biol 2, e123.
Irizarry, R.A., Hobbs, B., Collin, F., et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264.
Itasaki, N., and Hoppler, S. (2010). Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn 239, 16–33.
Jackson, A.L., Burchard, J., Schelter, J., et al. (2006). Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179–1187.
James, R.G., Biechele, T.L., Conrad, W.H., et al. (2009). Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Sci Signal 2, ra25.
James, R.G., Conrad, W.H., and Moon, R.T. (2008). Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods Mol Biol 468, 131–144.
Jenny, A., and Mlodzik, M. (2006). Planar cell polarity signaling: a common mechanism for cellular polarization. Mt Sinai J Med 73, 738–750.
Jensen, P.B., Pedersen, L., Krishna, S., and Jensen, M.H. (2010). A Wnt oscillator model for somitogenesis. Biophysical J 98, 943–950.
Jessen, J.R. (2009). Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish 6, 21–28.
Jin, T., George Fantus, I., and Sun, J. (2008). Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal 20, 1697–1704.
Kanehisa, M., Goto, S., Hattori, M., et al. (2006). From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34, D354–357.
Karaguni, I.M., Gourzoulidou, E., Carpintero, M., et al. (2004). SMAF-1 inhibits the APC/beta-catenin pathway and shows properties similar to those of the tumor suppressor protein APC. Chembiochem 5, 1267–1270.
Katoh, M. (2007). Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 3, 30–38.
Keating, G.M., and Santoro, A. (2009). Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs 69, 223–240.
Keshava Prasad, T.S., Goel, R., Kandasamy, K., et al. (2009). Human Protein Reference Database – 2009 update. Nucleic Acids Res 37, D767–772.
Kestler, H.A., and Kuhl, M. (2008). From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc Lond B Biol Sci 363, 1333–1347.
Khramtsov, A.I., Khramtsova, G.F., Tretiakova, M., et al. (2010). Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 176, 2911–2920.
Kikuchi, A., and Yamamoto, H. (2008). Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 99, 202–208.
Kikuchi, A., Yamamoto, H., and Kishida, S. (2007). Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 19, 659–671.
Kim, D., Rath, O., Kolch, W., and Cho, K.H. (2007). A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways. Oncogene 26, 4571–4579.
Kim, K., and Hay, E.D. (2001). New evidence that nuclear import of endogenous beta-catenin is LEF-1 dependent, while LEF-1 independent import of exogenous beta-catenin leads to nuclear abnormalities. Cell Biol Int 25, 1149–1161.
Köcher, T., and Superti-Furga, G. (2007). Mass spectrometry-based functional proteomics: from molecular machines to protein networks. Nat Methods 4, 807–815.
Kohler, F., and Muller, K.M. (2003). Adaptation of the Ras-recruitment system to the analysis of interactions between membrane-associated proteins. Nucleic Acids Res 31, e28.
Kohn, A.D., and Moon, R.T. (2005). Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38, 439–446.
Komiya, Y., and Habas, R. (2008). Wnt signal transduction pathways. Organogenesis 4, 68–75.
Kool, M., Koster, J., Bunt, J., et al. (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3, e3088.
Korinek, V., Barker, N., Morin, P.J., et al. (1997a). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC–/– colon carcinoma. Science 275, 1784–1787.
Korinek, V., Barker, N., Morin, P.J., et al. (1997b). Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC–/– colon carcinoma. Science 275, 1784–1787.
Krogan, N.J., Cagney, G., Yu, H., et al. (2006). Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440, 637–643.
Kruger, R., and Heinrich, R. (2004). Model reduction and analysis of robustness for the Wnt/beta-catenin signal transduction pathway. Genome Informatics 15, 138–148.
Kuhl, M. (2004). The WNT/calcium pathway: biochemical mediators, tools and future requirements. Front Biosci 9, 967–974.
Kuhl, M., and Pandur, P. (2008a). Dorsal axis duplication as a functional readout for Wnt activity. Methods Mol Biol 469, 467–476.
Kuhl, M., and Pandur, P. (2008b). Measuring CamKII activity in Xenopus embryos as a read-out for non-canonical Wnt signaling. Methods Mol Biol 468, 173–186.
Lai, S.L., Chien, A.J., and Moon, R.T. (2009). Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res 19, 532–545.
Landesman-Bollag, E., Romieu-Mourez, R., Song, D.H., et al. (2001). Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20, 3247–3257.
Lee, E., Salic, A., Kruger, R., Heinrich, R., and Kirschner, M.W. (2003). The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1, e10.
Lepourcelet, M., Chen, Y.N., France, D.S., et al. (2004). Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5, 91–102.
Li, H., Helling, R., Tang, C., and Wingreen, N. (1996). Emergence of preferred structures in a simple model of protein folding. Science 273, 666–669.
Liang, P., and Pardee, A.B. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.
Lievens, S., Lemmens, I., and Tavernier, J. (2009). Mammalian two-hybrids come of age. Trends Biochem Sci 34, 579–588.
Lin, S.Y., Xia, W., Wang, J.C., et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97, 4262–4266.
Liu, J., Bang, A.G., Kintner, C., et al. (2005). Identification of the Wnt signaling activator leucine-rich repeat in Flightless interaction protein 2 by a genome-wide functional analysis. Proc Natl Acad Sci USA 102, 1927–1932.
Logan, C.Y., and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781–810.
Lu, J., Ma, Z., Hsieh, J.C., et al. (2009). Structure-activity relationship studies of small-molecule inhibitors of Wnt response. Bioorg Med Chem Lett 19, 3825–3827.
Ma, D., Amonlirdviman, K., Raffard, R.L., et al. (2008). Cell packing influences planar cell polarity signaling. Proc Natl Acad Sci USA 105, 18800–18805.
Ma, W., Lai, L., Ouyang, Q., and Tang, C. (2006). Robustness and modular design of the Drosophila segment polarity network. Mol Syst Biol 2, 70.
MacDonald, B.T., Tamai, K., and He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17, 9–26.
Mahmoudi, T., Li, V.S.W., Ng, S.S., et al. (2009). The kinase TNIK is an essential activator of Wnt target genes. EMBO J 28, 3329–3340.
Major, M.B., Camp, N.D., Berndt, J.D., et al. (2007). Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316, 1043–1046.
Major, M.B., Roberts, B.S., Berndt, J.D., et al. (2008). New regulators of Wnt/beta-catenin signaling revealed by integrative molecular screening. Sci Signal 1, ra12.
Matushansky, I., Maki, R.G., and Cordon-Cardo, C. (2008). A context dependent role for Wnt signaling in tumorigenesis and stem cells. Cell Cycle 7, 720–724.
McDonald, S.L., and Silver, A. (2009). The opposing roles of Wnt-5a in cancer. Br J Cancer 101, 209–214.
McMahon, A.P., and Moon, R.T. (1989). Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 58, 1075–1084.
McNeill, H., and Woodgett, J.R. (2010). When pathways collide: collaboration and connivance among signalling proteins in development. Nat Rev Mol Cell Biol 11, 404–413.
Meijer, L., and Raymond, E. (2003). Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res 36, 417–425.
Meinhardt, H., and Gierer, A. (1980). Generation and regeneration of sequence of structures during morphogenesis. J Theoret Biol 85, 429–450.
Mi, H., and Thomas, P. (2009). PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Methods Mol Biol 563, 123–140.
Mikels, A.J., and Nusse, R. (2006). Wnts as ligands: processing, secretion and reception. Oncogene 25, 7461–7468.
Miyoshi, K., Rosner, A., Nozawa, M., et al. (2002). Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene 21, 5548–5556.
Moffat, J., and Sabatini, D.M. (2006). Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol 7, 177–187.
Moon, R.T., Kohn, A.D., De Ferrari, G.V., and Kaykas, A. (2004). WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5, 691–701.
Moore, W.J., Kern, J.C., Bhat, R., et al. (2010). Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: part II. Bioorg Med Chem 18, 190–201.
Moser, A.R., Dove, W.F., Roth, K.A., and Gordon, J.I. (1992). The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116, 1517–1526.
Mosimann, C., Hausmann, G., and Basler, K. (2009). Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10, 276–286.
Nath, N., Kashfi, K., Chen, J., and Rigas, B. (2003). Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc Natl Acad Sci USA 100, 12584–12589.
Niehrs, C., and Shen, J. (2010). Regulation of Lrp6 phosphorylation. Cell Mol Life Sci 67, 2551–2562.
Niida, A., Hiroko, T., Kasai, M., et al. (2004). DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23, 8520–8526.
Noordermeer, J., Klingensmith, J., Perrimon, N., and Nusse, R. (1994). Dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature 367, 80–83.
Nusse, R., Brown, A., Papkoff, J., et al. (1991). A new nomenclature for int-1 and related genes: the Wnt gene family. Cell 64, 231.
Nusse, R., and Varmus, H.E. (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31, 99–109.
O'Connell, M.P., and Weeraratna, A.T. (2009). Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt. Pigment Cell Melanoma Res 22, 724–739.
Ohkawara, B., and Niehrs, C. (2011). An ATF2-based luciferase reporter to monitor non-canonical Wnt signaling in Xenopus embryos. Dev Dyn 240, 188–194.
Papkoff, J. (1997). Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src. J Biol Chem 272, 4536–4543.
Parikh, J.R., Klinger, B., Xia, Y., Marto, J.A., and Bluthgen, N. (2010). Discovering causal signaling pathways through gene-expression patterns. Nucleic Acids Res 38, W109–117.
Park, C.H., Chang, J.Y., Hahm, E.R., et al. (2005). Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 328, 227–234.
Park, S., Gwak, J., Cho, M., et al. (2006). Hexachlorophene inhibits Wnt/{beta}-catenin pathway by promoting Siah-mediated {beta}-catenin degradation. Mol Pharmacol 70, 960–966.
Pico, A.R., Kelder, T., van Iersel, M.P., et al. (2008). WikiPathways: pathway editing for the people. PLoS Biol 6, e184.
Playford, M.P., Bicknell, D., Bodmer, W.F., and Macaulay, V.M. (2000). Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci USA 97, 12103–12108.
Polakis, P. (2000). Wnt signaling and cancer. Genes Dev 14, 1837–1851.
Polakis, P. (2007). The many ways of Wnt in cancer. Curr Opin Genet Dev 17, 45–51.
Port, F., and Basler, K. (2010). Wnt trafficking: new insights into Wnt maturation, secretion and spreading. Traffic 11, 1265–1271.
Pukrop, T., and Binder, C. (2008). The complex pathways of Wnt 5a in cancer progression. J Mol Med 86, 259–266.
Rao, T.P., and Kuhl, M. (2010). An updated overview on Wnt signaling pathways: a prelude for more. Circ Res 106, 1798–1806.
Reya, T., and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843–850.
Rijsewijk, F., van Deemter, L., Wagenaar, E., Sonnenberg, A., and Nusse, R. (1987). Transfection of the int-1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation and tumorigenicity. EMBO J 6, 127–131.
Rivera, M.N., Kim, W.J., Wells, J., et al. (2007). An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315, 642–645.
Rodriguez-Gonzalez, J.G., Santillan, M., Fowler, A.C., and Mackey, M.C. (2007). The segmentation clock in mice: interaction between the Wnt and Notch signalling pathways. J Theoret Biol 248, 37–47.
Roelink, H., Wagenaar, E., Lopes da Silva, S., and Nusse, R. (1990). Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Proc Natl Acad Sci USA 87, 4519–4523.
Roelink, H., Wagenaar, E., and Nusse, R. (1992). Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 7, 487–492.
Röhrs, S., Kutzner, N., Vlad, A., et al. (2009). Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3. Cell Biol Int 33, 501–508.
Röhrs, S.a.M., O. (2007). The Wnt pathway as a target for small synthetic anti-cancer molecules. Curr Chem Biol 1, 227–239.
Ronaghi, M. (2001). Pyrosequencing sheds light on DNA sequencing. Genome Res 11, 3–11.
Ronaghi, M., Uhlen, M., and Nyren, P. (1998). A sequencing method based on real-time pyrophosphate. Science 281, 363–365.
Rossol-Allison, J., Stemmle, L.N., Swenson-Fields, K.I., et al. (2009). Rho GTPase activity modulates Wnt3a/beta-catenin signaling. Cell Signal 21, 1559–1568.
Roszko, I., Sawada, A., and Solnica-Krezel, L. (2009). Regulation of convergence and extension movements during vertebrate gastrulation by the Wnt/PCP pathway. Semin Cell Dev Biol 20, 986–997.
Saadeddin, A., Babaei-Jadidi, R., Spencer-Dene, B., and Nateri, A.S. (2009). The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol Cancer Res 7, 1189–1196.
Sansom, O.J., Reed, K.R., Hayes, A.J., et al. (2004). Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18, 1385–1390.
Sansom, O.J., Reed, K.R., van de Wetering, M., et al. (2005). Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 280, 28463–28467.
Saraswati, S., Alfaro, M.P., Thorne, C.A., et al. (2010). Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS One 5, e15521.
Satoh, S., Daigo, Y., Furukawa, Y., et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24, 245–250.
Satow, R., Shitashige, M., Jigami, T., et al. (2010). Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation. J Biol Chem 285, 26289–26294.
Schena, M., Shalon, D., Davis, R.W., and Brown, P.O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.
Schlessinger, K., Hall, A., and Tolwinski, N. (2009). Wnt signaling pathways meet Rho GTPases. Genes Dev 23, 265–277.
Segditsas, S., Sieber, O., Deheragoda, M., et al. (2008). Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice. Hum Mol Genet 17, 3864–3875.
Selbach, M., and Mann, M. (2006). Protein interaction screening by quantitative immunoprecipitation combined with knockdown (QUICK). Nat Methods 3, 981–983.
Semenov, M.V., Tamai, K., Brott, B.K., et al. (2001). Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11, 951–961.
Sethi, J.K., and Vidal-Puig, A. (2010). Wnt signalling and the control of cellular metabolism. Biochem J 427, 1–17.
Shan, J., Shi, D.L., Wang, J., and Zheng, J. (2005). Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry 44, 15495–15503.
Shapiro, G.I. (2006). Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24, 1770–1783.
Shimizu, M., Fukunaga, Y., Ikenouchi, J., and Nagafuchi, A. (2008). Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells. Mol Cell Biol 28, 825–835.
Shin, S.Y., Rath, O., Zebisch, A., et al. (2010). Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Res 70, 6715–6724.
Shitashige, M., Satow, R., Jigami, T., et al. (2010). Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth. Cancer Res 70, 5024–5033.
Shtutman, M., Zhurinsky, J., Simcha, I., et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522–5527.
Sick, S., Reinker, S., Timmer, J., and Schlake, T. (2006). WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism. Science 314, 1447–1450.
Simons, M., and Mlodzik, M. (2008). Planar cell polarity signaling: from fly development to human disease. Annu Rev Genet 42, 517–540.
Smith, W.C., and Harland, R.M. (1991). Injected Xwnt-8 RNA acts early in Xenopus embryos to promote formation of a vegetal dorsalizing center. Cell 67, 753–765.
Sokol, S., Christian, J.L., Moon, R.T., and Melton, D.A. (1991). Injected Wnt RNA induces a complete body axis in Xenopus embryos. Cell 67, 741–752.
Song, D.H., Dominguez, I., Mizuno, J., et al. (2003). CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J Biol Chem 278, 24018–24025.
Sowa, M.E., Bennett, E.J., Gygi, S.P., and Harper, J.W. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389–403.
Stagljar, I. (2003). Finding partners: emerging protein interaction technologies applied to signaling networks. Sci STKE 2003, pe56.
Stark, C., Breitkreutz, B.J., Reguly, T., et al. (2006). BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34, D535–539.
Stelzl, U., Worm, U., Lalowski, M., et al. (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell 122, 957–968.
Su, L., Kinzler, K., Vogelstein, B., et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668–670.
Subramanian, A., Tamayo, P., Mootha, V.K., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545–15550.
Svedlund, J., Auren, M., Sundstrom, M., et al. (2010). Aberrant WNT/beta-catenin signaling in parathyroid carcinoma. Mol Cancer 9, 294.
Takahashi-Yanaga, F., and Kahn, M. (2010). Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16, 3153–3162.
Takahashi-Yanaga, F., and Sasaguri, T. (2009). Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. J Pharmacol Sci 109, 179–183.
Takemaru, K.-I., Yamaguchi, S., Lee, Y.S., et al. (2003). Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422, 905–909.
Takemaru, K.I., Ohmitsu, M., and Li, F.Q. (2008). An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics. Handb Exp Pharmacol, 261–284.
Tang, L.Y., Deng, N., Wang, L.S., et al. (2007). Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction. Mol Cell Proteomics 6, 1952–1967.
Tang, W., Dodge, M., Gundapaneni, D., et al. (2008). A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Nat Acad Sci USA 105, 9697–9702.
Trosset, J.Y., Dalvit, C., Knapp, S., et al. (2006). Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening. Proteins 64, 60–67.
Turing, A.M. (1952). The chemical basis of morphogenesis. Philos Trans R Soc Lond B Biol Sci 237, 37–72.
van Amerongen, R., and Berns, A. (2006). Knockout mouse models to study Wnt signal transduction. Trends Genet 22, 678–689.
van Amerongen, R., and Nusse, R. (2009). Towards an integrated view of Wnt signaling in development. Development 136, 3205–3214.
van de Wetering, M., Sancho, E., Verweij, C., et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241–250.
van Erk, M.J., Roepman, P., van der Lende, T.R., et al. (2005). Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44, 143–156.
Veeman, M.T., Slusarski, D.C., Kaykas, A., Louie, S.H., and Moon, R.T. (2003). Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr Biol 13, 680–685.
Verheyen, E.M., and Gottardi, C.J. (2010). Regulation of Wnt/beta-catenin signaling by protein kinases. Dev Dyn 239, 34–44.
Verkaar, F., and Zaman, G.J. (2011). New avenues to target Wnt/beta-catenin signaling. Drug Discov Today 16, 35–41.
Vlad, A., Röhrs, S., Klein-Hitpass, L., and Müller, O. (2008). The first five years of the Wnt targetome. Cell Signal 20, 795–802.
von Dassow, G., Meir, E., Munro, E.M., and Odell, G.M. (2000). The segment polarity network is a robust developmental module. Nature 406, 188–192.
von Dassow, G., and Odell, G.M. (2002). Design and constraints of the Drosophila segment polarity module: robust spatial patterning emerges from intertwined cell state switches. J Exp Zoology 294, 179–215.
Wallingford, J.B., and Habas, R. (2005). The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development 132, 4421–4436.
Wang, Y. (2009). Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 8, 2103–2109.
Wawra, C., Kuhl, M., and Kestler, H.A. (2007). Extended analyses of the Wnt/beta-catenin pathway: robustness and oscillatory behaviour. FEBS Lett 581, 4043–4048.
Wharton, K.A., Jr. (2003). Runnin’ with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol 253, 1–17.
Willert, J., Epping, M., Pollack, J.R., Brown, P.O., and Nusse, R. (2002). A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2, 8.
Wu, X., Tu, X., Joeng, K.S., et al. (2008). Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133, 340–353.
Xia, Y., and Levitt, M. (2004). Simulating protein evolution in sequence and structure space. Curr Opin Struct Biol 14, 202–207.
Ye, C., Sweeny, D., Sukbuntherng, J., et al. (2006). Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416. Toxicol In Vitro 20, 154–162.
Yin, X., Giap, C., Lazo, J.S., and Prochownik, E.V.(2003). Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22, 6151–6159.
Yu, H., Braun, P., Yildirim, M.A., et al. (2008). High-quality binary protein interaction map of the yeast interactome network. Science 322, 104–110.
Zhang, Q., Major, M.B., Takanashi, S., et al. (2007). Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci USA 104, 7444–7448.
Zhang, Y., Askenazi, M., Jiang, J., et al. (2010). A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia. Mol Cell Proteomics 9, 780–790.
Zhou, L., An, N., Haydon, R.C., et al. (2003). Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett 193, 161–170.
Ziegler, S., Rohrs, S., Tickenbrock, L., et al. (2005). Novel target genes of the Wnt pathway and statistical insights into Wnt target promoter regulation. FEBS J 272, 1600–1615.